A Retrospective Chart Review Evaluating Changes in 25-Hydroxyvitamin D Levels among Patients Attending the University Healthcare Centre during the COVID-19 Pandemic.

Tarek Benameur, Feroze Kaliyadan, Neji Saidi, Chiara Porro

Abstract read

In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tarek BenameurDepartment of Biomedical Sciences, College of Medicine, King Faisal University, Al Ahsa 31982, Saudi Arabia.

Feroze KaliyadanSree Narayana Institute of Medical Sciences, Kerala University of Health Sciences, Thrissur 683594, India.

Neji SaidiDepartment of Mathematics and Statistics, College of Sciences, King Faisal University, Al Ahsa 31982, Saudi Arabia.ORCID 0000-0002-3832-1593

Chiara PorroDepartment of Clinical and Experimental Medicine, University of Foggia, 71121 Foggia, Italy.ORCID 0000-0002-7526-6968

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19-pandemic-related home confinement aids in limiting the spread of the virus but restricts exposure to sunlight, thereby possibly affecting 25(OH)D concentrations. This study aimed to investigate the effect of lockdown measures on 25(OH)D levels in outpatients visiting the healthcare centre over a period of two years. In this retrospective chart review, outpatients who visited a university healthcare centre for a health check-up over a period of two years were included. The patients' 25(OH)D serum levels and status were compared before, during, and after the lockdown periods. A total of 7234 patients were included in this study, with a mean age of 34.66 ± 16.78. The overall prevalence of 25(OH)D insufficiency, deficiency and sufficiency was 33.8%, 30.7% and 35.4%, respectively. The proportion of individuals with 25-(OH) D deficiency prior to lockdown was 29% and this proportion increased in the lockdown and post-lockdown periods to 31.1% and 32%, respectively. Although gender was less likely to have an impact on the 25 (OH) D level during the lockdown period (

Indexed as

COVID-19Vitamin D DeficiencyAdolescentAdultCalcifediolChildChild, PreschoolCommunicable Disease ControlDelivery of Health CareHumansInfantMaleMiddle AgedPandemicsRetrospective StudiesRisk Factors25-hydroxyvitamin DCalcifediolVitamin DVitamins25-hydroxyvitamin Dcoronavirus diseaseCOVID-19deficiencyhome confinementinsufficiencylockdownpandemicpost-lockdownpre-lockdownSaudi Arabiavitamin D

Identifiers

PMID37242228

DOI10.3390/nu15102345

PMCPMC10223421

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.